{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:34:15Z","timestamp":1792611255893,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10620-026-10056-y","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:18:20Z","timestamp":1782141500000},"page":"4994-5002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recompensation and Further Decompensation After Index Decompensation in Patients with Autoimmune Hepatitis: A Real-World Study"],"prefix":"10.1007","volume":"71","author":[{"given":"Arnav","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarthak","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umang","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samagra","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"10056_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007708","volume":"96","author":"\u00c5D Borss\u00e9n","year":"2017","unstructured":"Borss\u00e9n \u00c5D, Palmqvist R, Kechagias S et al. Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: a cohort study. Medicine (Baltimore). 2017;96:e7708. https:\/\/doi.org\/10.1097\/MD.0000000000007708.","journal-title":"Medicine (Baltimore)."},{"key":"10056_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/apt.12592","volume":"39","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther. 2014;39:385\u2013406. https:\/\/doi.org\/10.1111\/apt.12592.","journal-title":"Aliment Pharmacol Ther."},{"key":"10056_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09129-1","author":"A Aggarwal","year":"2025","unstructured":"Aggarwal A, Swaroop S, Biswas S, Mehta S, Saxena S, Bayye R et al. Efficacy, safety and long-term clinical outcomes of low-dose versus high-dose prednisolone induction in autoimmune hepatitis: a propensity score-matched analysis. Dig Dis Sci. 2025. https:\/\/doi.org\/10.1007\/s10620-025-09129-1.","journal-title":"Dig Dis Sci."},{"key":"10056_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jceh.2022.11.002","volume":"13","author":"S Taneja","year":"2023","unstructured":"Taneja S, Mehtani R, De A et al. Spectrum of autoimmune liver disease and real-world treatment experience from a tertiary care hospital. J Clin Exp Hepatol. 2023;13:241\u2013251.","journal-title":"J Clin Exp Hepatol."},{"key":"10056_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G et al. Baveno VII \u2013 Renewing consensus in portal hypertension. J Hepatol. 2022;76:959\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022.","journal-title":"J Hepatol."},{"key":"10056_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101496","volume":"7","author":"Y Chen","year":"2025","unstructured":"Chen Y, Wen H, Li Y et al. Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy. JHEP Rep. 2025;7:101496. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101496.","journal-title":"JHEP Rep."},{"key":"10056_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.02.010","author":"P Arvaniti","year":"2025","unstructured":"Arvaniti P, Rodr\u00edguez-Tajes S, Padilla M et al. Hepatic encephalopathy and MELD-Na predict treatment benefit in autoimmune hepatitis-related decompensated cirrhosis. Clin Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.cgh.2025.02.010.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10056_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli P, Bernardi M, Villanueva C et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u2013460. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024.","journal-title":"J Hepatol."},{"key":"10056_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.04.026","author":"G Semmler","year":"2025","unstructured":"Semmler G, Lens S, Hidalgo \u00c1 et al. Incidence and clinical significance of recompensation after HCV cure. Clin Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.cgh.2025.04.026.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10056_CR10","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/liv.15676","volume":"43","author":"BS Hofer","year":"2023","unstructured":"Hofer BS, Simbrunner B, Hartl, et al. Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis. Liver International 2023;43:2220\u20132231.","journal-title":"Liver International"},{"key":"10056_CR11","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.jhep.2022.07.037","volume":"77","author":"Q Wang","year":"2022","unstructured":"Wang Q, Zhao H, Deng Y et al. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis. J Hepatol. 2022;77:1564\u20131572. https:\/\/doi.org\/10.1016\/j.jhep.2022.07.037.","journal-title":"J Hepatol."},{"key":"10056_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1053\/j.gastro.2024.08.018","volume":"167","author":"M Premkumar","year":"2024","unstructured":"Premkumar M, Dhiman RK, Duseja A et al. Recompensation of chronic hepatitis c-related decompensated cirrhosis following direct-acting antiviral therapy: prospective cohort study from a hepatitis C virus elimination program. Gastroenterology. 2024;167:1429\u20131445. https:\/\/doi.org\/10.1053\/j.gastro.2024.08.018.","journal-title":"Gastroenterology."},{"key":"10056_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2025.02.041","volume":"83","author":"Y S\u00e1nchez-Torrijos","year":"2025","unstructured":"S\u00e1nchez-Torrijos Y, Fern\u00e1ndez-\u00c1lvarez P, Rosales JM, z et al. Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C. J Hepatol. 2025;83:652\u2013661. https:\/\/doi.org\/10.1016\/j.jhep.2025.02.041.","journal-title":"J Hepatol."},{"key":"10056_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101562","volume":"7","author":"\u00c1 D\u00edaz-Gonz\u00e1lez","year":"2025","unstructured":"D\u00edaz-Gonz\u00e1lez \u00c1, Schregel I, Carballo L et al. Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis. JHEP Rep. 2025;7:101562. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101562.","journal-title":"JHEP Rep."},{"key":"10056_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101149","author":"L Grossar","year":"2024","unstructured":"Grossar L, Raevens S, Steenkiste CV et al. External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort. JHEP Rep. 2024. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101149.","journal-title":"JHEP Rep"},{"key":"10056_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/liv.14082","volume":"39","author":"J Choi","year":"2019","unstructured":"Choi J, Choi GH, Lee D et al. Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country. Liver Int. 2019;39:985\u2013994. https:\/\/doi.org\/10.1111\/liv.14082.","journal-title":"Liver Int."},{"key":"10056_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","volume":"83","author":"G Dalekos","year":"2025","unstructured":"Dalekos G, Gatselis N, Drenth JP et al. EASL Clinical Practice Guidelines on the management of autoimmune hepatitis. J Hepatol. 2025;83:453\u2013501. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.017.","journal-title":"J Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10056-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:03:15Z","timestamp":1789052595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10056-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10056"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10056-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institute Ethics Committee.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was waived off due to retrospective nature of the study.","order":3,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}